Zobrazeno 1 - 10
of 69
pro vyhledávání: '"C F, Meares"'
Publikováno v:
Biochemistry. 40:3184-3188
By exploiting substrate protection of Cys148 in lactose permease, a methanethiosulfonate nitroxide spin-label was directed specifically to one of two Cys residues in a double-Cys mutant, followed by labeling of Cys148 with a thiol-reactive chelator t
Autor:
Donald T. Corson, C F Meares
Publikováno v:
Bioconjugate Chemistry. 11:292-299
We have developed and optimized the synthesis of the title compound, eliminating all HPLC purifications prior to the final product. The yield (and scale) of the synthesis was increased from 19% (200 mg) to 75% (26 g).
Publikováno v:
Acta Crystallographica Section C Crystal Structure Communications. 51:621-623
The structure was solved by the Patterson method and suc- cessive Fourier electron density difference maps, and refined by full-matrix least-squares procedures with anisotropic tem- perature factors for all non-H atoms. The positions of all H atoms w
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 42(9)
Radiometal-labeled monoclonal antibodies are retained longer in tumors than iodinated antibodies, leading to their increased use for radioimmunotherapy. Dissociation of radioiodine from the antibody during metabolism has been documented. We now repor
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 42(4)
Biodistribution and dosimetry of 88Y (and equimolar 90Y) Janus-dodecanetetraacetic acid (DOTA) were performed using a three-step pretargeting protocol in BALB/c mice bearing mouse mammary adenocarcinoma (KHJJ) implants. Pretargeting was performed wit
Autor:
S A, Datwyler, C F, Meares
Publikováno v:
Metal ions in biological systems. 38
Autor:
S. A. Datwyler, C. F. Meares
Publikováno v:
Trends in biochemical sciences. 25(10)
Autor:
G L, DeNardo, R T, O'Donnell, S, Shen, L A, Kroger, A, Yuan, C F, Meares, D L, Kukis, S J, DeNardo
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 41(5)
Several monoclonal antibodies, including Lym-1, have proven effective for treatment of hematologic malignancies. Lym-1, which preferentially targets malignant lymphocytes, has induced therapeutic responses and prolonged survival in patients with non-
Autor:
C F, Meares
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5(3)
Antilymphoma mouse monoclonal antibody (MoAb) Lym-1, labeled with 67Cu or 131I, has demonstrated promising results in radioimmunotherapy (RIT) for lymphoma. Although 131I has played a central role in RIT thus far, some properties of 67Cu are preferab